202 related articles for article (PubMed ID: 38782062)
1. Glycosylated nanoplatforms: From glycosylation strategies to implications and opportunities for cancer theranostics.
Zare I; Zirak Hassan Kiadeh S; Varol A; Ören Varol T; Varol M; Sezen S; Zarepour A; Mostafavi E; Zahed Nasab S; Rahi A; Khosravi A; Zarrabi A
J Control Release; 2024 Jul; 371():158-178. PubMed ID: 38782062
[TBL] [Abstract][Full Text] [Related]
2. Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise.
Chen Q; Liu Z
Adv Mater; 2016 Dec; 28(47):10557-10566. PubMed ID: 27111654
[TBL] [Abstract][Full Text] [Related]
3. Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.
Sun W; Li S; Tang G; Luo Y; Ma S; Sun S; Ren J; Gong Y; Xie C
Int J Nanomedicine; 2019; 14():10195-10207. PubMed ID: 32099352
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
[TBL] [Abstract][Full Text] [Related]
5. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
6. Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.
Chen Z; Krishnamachary B; Pachecho-Torres J; Penet MF; Bhujwalla ZM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1595. PubMed ID: 31642207
[TBL] [Abstract][Full Text] [Related]
7. Magnetic nanoparticles based cancer therapy: current status and applications.
Zhang H; Liu XL; Zhang YF; Gao F; Li GL; He Y; Peng ML; Fan HM
Sci China Life Sci; 2018 Apr; 61(4):400-414. PubMed ID: 29675551
[TBL] [Abstract][Full Text] [Related]
8. Recent advances of polymeric nanoplatforms for cancer treatment: smart delivery systems (SDS), nanotheranostics and multidrug resistance (MDR) inhibition.
Gupta U; Maity D; Sharma VK
Biomed Mater; 2023 Nov; 19(1):. PubMed ID: 37944188
[TBL] [Abstract][Full Text] [Related]
9. Cancer theranostic applications of lipid-based nanoparticles.
Tang WL; Tang WH; Li SD
Drug Discov Today; 2018 May; 23(5):1159-1166. PubMed ID: 29660478
[TBL] [Abstract][Full Text] [Related]
10. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
Cai Y; Chen X; Si J; Mou X; Dong X
Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
[TBL] [Abstract][Full Text] [Related]
11. 2D Nanomaterials for Cancer Theranostic Applications.
Cheng L; Wang X; Gong F; Liu T; Liu Z
Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
[TBL] [Abstract][Full Text] [Related]
12. Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.
Choi KY; Liu G; Lee S; Chen X
Nanoscale; 2012 Jan; 4(2):330-42. PubMed ID: 22134683
[TBL] [Abstract][Full Text] [Related]
13. Strategies and applications of covalent organic frameworks as promising nanoplatforms in cancer therapy.
Valenzuela C; Chen C; Sun M; Ye Z; Zhang J
J Mater Chem B; 2021 Apr; 9(16):3450-3483. PubMed ID: 33909746
[TBL] [Abstract][Full Text] [Related]
14. New insight into the engineering of green carbon dots: Possible applications in emerging cancer theranostics.
Radnia F; Mohajeri N; Zarghami N
Talanta; 2020 Mar; 209():120547. PubMed ID: 31892009
[TBL] [Abstract][Full Text] [Related]
15. Copper sulfide: An emerging adaptable nanoplatform in cancer theranostics.
Poudel K; Gautam M; Jin SG; Choi HG; Yong CS; Kim JO
Int J Pharm; 2019 May; 562():135-150. PubMed ID: 30904728
[TBL] [Abstract][Full Text] [Related]
16. Neodymium doped hydroxyapatite theranostic nanoplatforms for colon specific drug delivery applications.
Victor SP; Paul W; Vineeth VM; Komeri R; Jayabalan M; Sharma CP
Colloids Surf B Biointerfaces; 2016 Sep; 145():539-547. PubMed ID: 27281239
[TBL] [Abstract][Full Text] [Related]
17. Melanin-based nanomaterials: The promising nanoplatforms for cancer diagnosis and therapy.
Hong ZY; Feng HY; Bu LH
Nanomedicine; 2020 Aug; 28():102211. PubMed ID: 32320736
[TBL] [Abstract][Full Text] [Related]
18. Metal nanoparticles: a theranostic nanotool against cancer.
Sharma H; Mishra PK; Talegaonkar S; Vaidya B
Drug Discov Today; 2015 Sep; 20(9):1143-51. PubMed ID: 26007605
[TBL] [Abstract][Full Text] [Related]
19. Metal-phenolic networks for cancer theranostics.
Liu P; Shi X; Zhong S; Peng Y; Qi Y; Ding J; Zhou W
Biomater Sci; 2021 Apr; 9(8):2825-2849. PubMed ID: 33688863
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale theranostics for physical stimulus-responsive cancer therapies.
Chen Q; Ke H; Dai Z; Liu Z
Biomaterials; 2015 Dec; 73():214-30. PubMed ID: 26410788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
